TH178679A - Using a molecule that binds semaphorin -4D For the treatment of disease disorders that are Destruction of nerve cells in the brain (neurodegenerative disorder) - Google Patents

Using a molecule that binds semaphorin -4D For the treatment of disease disorders that are Destruction of nerve cells in the brain (neurodegenerative disorder)

Info

Publication number
TH178679A
TH178679A TH1601002196A TH1601002196A TH178679A TH 178679 A TH178679 A TH 178679A TH 1601002196 A TH1601002196 A TH 1601002196A TH 1601002196 A TH1601002196 A TH 1601002196A TH 178679 A TH178679 A TH 178679A
Authority
TH
Thailand
Prior art keywords
destruction
brain
molecule
treatment
nerve cells
Prior art date
Application number
TH1601002196A
Other languages
Thai (th)
Other versions
TH1601002196A (en
Inventor
เอส. สมิธ เออร์เนสท์
เซาเดอเรอ มัวไรซ์
เจ. โบเวอร์ส วิลเลียม
โจนาสัน อลัน
Original Assignee
นาย สัตยะพล สัจจเดชะ
นาย กฤชวัชร์ ชัยนภาศักดิ์
Filing date
Publication date
Application filed by นาย สัตยะพล สัจจเดชะ, นาย กฤชวัชร์ ชัยนภาศักดิ์ filed Critical นาย สัตยะพล สัจจเดชะ
Publication of TH178679A publication Critical patent/TH178679A/en
Publication of TH1601002196A publication Critical patent/TH1601002196A/en

Links

Claims (1)

: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : แท็ก :: Privilege (number one) which will appear on the advertisement page: Tag:
TH1601002196A 2014-10-21 Use of semaphorin-4D binding molecule For the treatment of disease disorders Destruction of nerve cells in the brain (neurodegenerative disorder) TH1601002196A (en)

Publications (2)

Publication Number Publication Date
TH178679A true TH178679A (en) 2018-08-09
TH1601002196A TH1601002196A (en) 2018-08-09

Family

ID=

Similar Documents

Publication Publication Date Title
TH178679A (en) Using a molecule that binds semaphorin -4D For the treatment of disease disorders that are Destruction of nerve cells in the brain (neurodegenerative disorder)
TH1601002196A (en) Use of semaphorin-4D binding molecule For the treatment of disease disorders Destruction of nerve cells in the brain (neurodegenerative disorder)
TH1701003010A (en) Components for the treatment of schizophrenia
TH168759A (en) Bio-readily available minerals for plant health
TH1701001929A (en) Substitudate aminopureine compounds, their constituents, and their treatment methods
TH1601005470A (en) Gene Therapy Associated with Retinitis Picamentosa
TH1501005024A (en) Pharmaceutical constituents for the treatment of fungal infections.
TH1601003539A (en) The conjugate of ANT-HER2 antibody-drug
TH1501005539A (en) Heteroeryl compounds and their uses
TH179187A (en) Glycoconjugate Components for Immunosuppression / Therapy And using that
TH178073A (en) Column for oil purification
TH182311A (en) Synthetic artificial cortex
TH175712A (en) High-efficiency radiation-induced stimulation for the elements. That formed as needed and methods of use
TH1601003237A (en)
TH1701002034A (en) Composition and methods of use for the treatment of metabolic disorders
TH176529A (en) Antibody specific to FcRn
TH1601003681A (en) Applications of isosazoline compounds in poultry
TH1601001924A (en) Heterocyclic compounds and their use
TH143538S (en) "Lamp frame"
TH171939A (en) Aminopyrimidyl compounds Which are JAK inhibitors
TH1601005726A (en) New compound imidazobenzothiazole
TH156175A (en) Agricultural vehicles
TH1501003881A (en) Benzylamine derivatives
TH176299A (en) Biological treatment methods and biological treatment kits
TH1601004234A (en) Pharmaceutical constituents containing IgM